最近在帕克利塔克塞尔生物合成和调节方面的进展
Toby Coombe-Tennant1, Xiaoping Zhu2,3, Shihua Wu2,3,4
1Institute of Molecular Plant Sciences, School of Biological Sciences, University of Edinburgh, The King's Buildings, Edinburgh EH9 3BF, UK.
Journal of experimental botany
|May 23, 2024
概括
由于新的基因组和转录组数据,我们更好地了解了帕克利塔塞尔 (PTX) 生物合成和调节. 这些知识为在新宿主中生产这种必不可少的抗癌药物和改善其生产开辟了道路.
科学领域:
- 植物生物化学 植物生物化学
- 基因组学就是基因组学.
- 癌症治疗方法 癌症治疗方法
背景情况:
- 帕克利塔塞尔 (Paclitaxel,PTX) 是一种重要的抗癌药物,来源于树种.
- 由于新的癌症治疗应用,对PTX的需求正在增加.
- 了解PTX生物合成对于确保这种必需药物的稳定供应至关重要.
研究的目的:
- 审查最近在帕克利塔克塞尔 (PTX) 生物合成和调节方面的进展.
- 突出转录和基因组数据对理解PTX生产的影响.
- 探索改善PTX生产的策略,包括异质表达和表观遗传操纵.
主要方法:
- 关于PTX生物合成和调节的最新科学文献的综述.
- 对Taxus物种的转录基因数据的分析.
- 对Taxus基因组的基因组测序和注释的检查.
- 讨论植物细胞培养中的表观遗传调节机制.
主要成果:
- 为PTX生物合成阐明两个功能性基因组.
- 在异质宿主中确定产生PTX的新潜力.
- 更好地了解PTX生物合成的调节,包括表观遗传因素.
- 开发潜在的工具来操纵表观遗传调节以改善PTX生产.
结论:
- 基因组学和转录组学的进步显著改善了我们对PTX生物合成的理解.
- 鉴定的基因组和监管洞察力为PTX生产提供了新的策略.
- 向表观遗传调节是一种有希望的方法,可以克服长期细胞培养中的挑战,并提高PTX产量.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


